Pak Fah Yeow International Limited (0239.HK)
HKD 2.44
(0.41%)
HKD 2.44
(0.41%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.07 Million HKD | -0.0% |
| 2022 | 2.07 Million HKD | 0.0% |
| 2021 | 2.07 Million HKD | 0.0% |
| 2020 | 2.07 Million HKD | 0.0% |
| 2019 | 2.07 Million HKD | 0.0% |
| 2018 | 2.07 Million HKD | 0.0% |
| 2017 | 2.07 Million HKD | -0.05% |
| 2016 | 2.07 Million HKD | 0.0% |
| 2015 | 2.07 Million HKD | 0.0% |
| 2014 | - HKD | 0.0% |
| 2013 | - HKD | -100.0% |
| 2012 | 32.71 Million HKD | -40.94% |
| 2011 | 55.39 Million HKD | -8.94% |
| 2010 | 60.82 Million HKD | 227.87% |
| 2009 | 18.55 Million HKD | -8.8% |
| 2008 | 20.34 Million HKD | -8.56% |
| 2007 | 22.24 Million HKD | -6.44% |
| 2006 | 23.77 Million HKD | -5.49% |
| 2005 | 25.15 Million HKD | 0.0% |
| 2004 | - HKD | 0.0% |
| 2003 | - HKD | 0.0% |
| 2002 | - HKD | 0.0% |
| 2001 | - HKD | -100.0% |
| 2000 | 46.6 Million HKD | 19.88% |
| 1999 | 38.87 Million HKD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 2.07 Million HKD | 0.0% |
| 2023 FY | 2.07 Million HKD | -0.0% |
| 2023 Q4 | 2.07 Million HKD | 0.0% |
| 2023 Q2 | 2.07 Million HKD | 0.0% |
| 2022 Q4 | 2.07 Million HKD | 0.0% |
| 2022 Q2 | 2.07 Million HKD | 0.0% |
| 2022 FY | 2.07 Million HKD | 0.0% |
| 2021 Q2 | 2.07 Million HKD | 0.0% |
| 2021 Q4 | 2.07 Million HKD | 0.0% |
| 2021 FY | 2.07 Million HKD | 0.0% |
| 2020 FY | 2.07 Million HKD | 0.0% |
| 2020 Q2 | 2.07 Million HKD | 0.0% |
| 2020 Q4 | 2.07 Million HKD | 0.0% |
| 2019 FY | 2.07 Million HKD | 0.0% |
| 2019 Q4 | 2.07 Million HKD | 0.0% |
| 2019 Q2 | 2.07 Million HKD | 0.0% |
| 2018 FY | 2.07 Million HKD | 0.0% |
| 2018 Q2 | - HKD | 0.0% |
| 2018 Q4 | - HKD | 0.0% |
| 2017 Q4 | - HKD | 0.0% |
| 2017 Q2 | - HKD | 0.0% |
| 2017 FY | 2.07 Million HKD | -0.05% |
| 2016 Q2 | - HKD | 0.0% |
| 2016 Q4 | - HKD | 0.0% |
| 2016 FY | 2.07 Million HKD | 0.0% |
| 2015 FY | 2.07 Million HKD | 0.0% |
| 2015 Q4 | - HKD | 0.0% |
| 2015 Q2 | - HKD | 0.0% |
| 2014 FY | - HKD | 0.0% |
| 2014 Q4 | - HKD | 0.0% |
| 2014 Q2 | - HKD | 0.0% |
| 2013 Q4 | 45.03 Million HKD | 0.0% |
| 2013 FY | - HKD | -100.0% |
| 2013 Q2 | 43.61 Million HKD | 0.0% |
| 2012 Q4 | 32.71 Million HKD | 0.0% |
| 2012 Q2 | 48.36 Million HKD | 0.0% |
| 2012 FY | 32.71 Million HKD | -40.94% |
| 2011 Q2 | 57.22 Million HKD | 0.0% |
| 2011 FY | 55.39 Million HKD | -8.94% |
| 2011 Q4 | 55.39 Million HKD | 0.0% |
| 2010 Q2 | 17.64 Million HKD | 0.0% |
| 2010 Q4 | 60.82 Million HKD | 0.0% |
| 2010 FY | 60.82 Million HKD | 227.87% |
| 2009 Q4 | 18.55 Million HKD | 0.0% |
| 2009 FY | 18.55 Million HKD | -8.8% |
| 2008 FY | 20.34 Million HKD | -8.56% |
| 2007 FY | 22.24 Million HKD | -6.44% |
| 2006 FY | 23.77 Million HKD | -5.49% |
| 2005 FY | 25.15 Million HKD | 0.0% |
| 2004 FY | - HKD | 0.0% |
| 2003 FY | - HKD | 0.0% |
| 2002 FY | - HKD | 0.0% |
| 2001 FY | - HKD | -100.0% |
| 2000 FY | 46.6 Million HKD | 19.88% |
| 1999 FY | 38.87 Million HKD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | 99.791% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | 98.23% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | 99.249% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | 97.065% |
| Essex Bio-Technology Limited | 36.05 Million HKD | 94.251% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | 83.806% |
| PuraPharm Corporation Limited | 81.09 Million HKD | 97.444% |
| SSY Group Limited | 1.94 Billion HKD | 99.894% |
| JBM (Healthcare) Limited | 43.8 Million HKD | 95.267% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | 99.65% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 99.988% |